Literature DB >> 20977469

α1-Adrenoceptor-mediated contraction of rat aorta is partly mediated via transactivation of the epidermal growth factor receptor.

N Ulu1, H Gurdal, S W Landheer, M Duin, M O Guc, H Buikema, R H Henning.   

Abstract

BACKGROUND AND
PURPOSE: High level of plasma catecholamines is a risk factor for vascular diseases such as hypertension and atherosclerosis. Catecholamines induce hypertrophy of vascular smooth muscle through α(1) -adrenoceptors, which in cell culture involves the transactivation of epidermal growth factor receptor (EGFR). We hypothesized that EGFR transactivation was also involved in contractions of rat aorta mediated by α(1) -adrenoceptors. EXPERIMENTAL APPROACH: Thoracic aorta was isolated from 12-14 week old male Wistar rats. In vitro aortic contractile responses to cumulative doses of phenylephrine were characterized in the absence and presence of the EGFR kinase inhibitors, AG1478 and DAPH, in intact and endothelium-denuded rings. Involvement of signal transduction pathways was investigated by using heparin and inhibitors of Src, matrix metalloproteinase (MMP), extracellular signal-regulated kinase (ERK)1/2 and phosphatidyl inositol 3-kinase (PI3K). Phosphorylation of EGFR and ERK1/2 was measured after short-term phenylephrine or EGF stimulation in aorta segments in the presence of AG1478 and the PI3K inhibitor, wortmannin. KEY
RESULTS: AG1478 and DAPH concentration dependently attenuated phenylephrine-induced contractile responses in intact or endothelium-denuded aortic rings. Inhibition of PI3K (wortmannin and LY294002) but not heparin or inhibitors of Src or MMP, prevented the effect of AG1478 on the responses to phenylephrine. Phenylephrine induced phosphorylation of EGFR, which was partially blocked by AG1478. Phenylephrine also increased phosphorylation of ERK1/2, time-dependently and was blocked by AG1478 and wortmannin. CONCLUSIONS AND IMPLICATIONS: Contractions of rat thoracic aorta mediated by α(1) -adrenoceptors involved transactivation of EGFR, mediated via a PI3K and ERK1/2 dependent pathway.
© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977469      PMCID: PMC3000655          DOI: 10.1111/j.1476-5381.2010.00829.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  Arterial epidermal growth factor receptor expression in deoxycorticosterone acetate-salt hypertension.

Authors:  C Northcott; J A Florian; A Dorrance; S W Watts
Journal:  Hypertension       Date:  2001-12-01       Impact factor: 10.190

3.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.

Authors:  N Prenzel; E Zwick; H Daub; M Leserer; R Abraham; C Wallasch; A Ullrich
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

4.  The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor.

Authors:  S Maudsley; K L Pierce; A M Zamah; W E Miller; S Ahn; Y Daaka; R J Lefkowitz; L M Luttrell
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

5.  Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.

Authors:  A Kalmes; B R Vesti; G Daum; J A Abraham; A W Clowes
Journal:  Circ Res       Date:  2000-07-21       Impact factor: 17.367

Review 6.  The EGF receptor as central transducer of heterologous signalling systems.

Authors:  E Zwick; P O Hackel; N Prenzel; A Ullrich
Journal:  Trends Pharmacol Sci       Date:  1999-10       Impact factor: 14.819

7.  Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.

Authors:  Masanori Asakura; Masafumi Kitakaze; Seiji Takashima; Yulin Liao; Fuminobu Ishikura; Tsuyoshi Yoshinaka; Hiroshi Ohmoto; Koichi Node; Kohichiro Yoshino; Hiroshi Ishiguro; Hiroshi Asanuma; Shoji Sanada; Yasushi Matsumura; Hiroshi Takeda; Shintaro Beppu; Michihiko Tada; Masatsugu Hori; Shigeki Higashiyama
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

8.  Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt.

Authors:  S Eguchi; H Iwasaki; H Ueno; G D Frank; E D Motley; K Eguchi; F Marumo; Y Hirata; T Inagami
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

9.  Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis.

Authors:  Prabhakara Reddy Nagareddy; Fung Lan Chow; Li Hao; Xiang Wang; Tamiko Nishimura; Kathleen M MacLeod; John H McNeill; Carlos Fernandez-Patron
Journal:  Cardiovasc Res       Date:  2009-07-03       Impact factor: 10.787

10.  Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense.

Authors:  Shuntaro Kagiyama; Satoru Eguchi; Gerald D Frank; Tadashi Inagami; Yuan Clare Zhang; M Ian Phillips
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

View more
  11 in total

1.  Activation of Toll-like receptor 3 increases mouse aortic vascular smooth muscle cell contractility through ERK1/2 pathway.

Authors:  Trevor Hardigan; Kathryn Spitler; Takayuki Matsumoto; Maria Alicia Carrillo-Sepulveda
Journal:  Pflugers Arch       Date:  2015-03-01       Impact factor: 3.657

Review 2.  The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.

Authors:  A Rietz; Jp Spiers
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Enhanced p22phox expression impairs vascular function through p38 and ERK1/2 MAP kinase-dependent mechanisms in type 2 diabetic mice.

Authors:  Modar Kassan; Soo-Kyoung Choi; Maria Galán; Young-Ho Lee; Mohamed Trebak; Khalid Matrougui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-31       Impact factor: 4.733

4.  Augmented Pulmonary Vasoconstrictor Reactivity after Chronic Hypoxia Requires Src Kinase and Epidermal Growth Factor Receptor Signaling.

Authors:  Charles E Norton; Joshua R Sheak; Simin Yan; Laura Weise-Cross; Nikki L Jernigan; Benjimen R Walker; Thomas C Resta
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

Review 5.  Epidermal growth factors in the kidney and relationship to hypertension.

Authors:  Alexander Staruschenko; Oleg Palygin; Daria V Ilatovskaya; Tengis S Pavlov
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-01

6.  Moderate inappropriately high aldosterone/NaCl constellation in mice: cardiovascular effects and the role of cardiovascular epidermal growth factor receptor.

Authors:  Barbara Schreier; Sindy Rabe; Sabrina Winter; Stefanie Ruhs; Sigrid Mildenberger; Bettina Schneider; Maria Sibilia; Michael Gotthardt; Sabine Kempe; Karsten Mäder; Claudia Grossmann; Michael Gekle
Journal:  Sci Rep       Date:  2014-12-11       Impact factor: 4.379

7.  The (R)-enantiomer of the 6-chromanol derivate SUL-121 improves renal graft perfusion via antagonism of the α1-adrenoceptor.

Authors:  D Nakladal; H Buikema; A Reyes Romero; S P H Lambooy; J Bouma; G Krenning; P Vogelaar; A C van der Graaf; M R Groves; J Kyselovic; R H Henning; L E Deelman
Journal:  Sci Rep       Date:  2019-01-09       Impact factor: 4.379

8.  Alpha1a-Adrenoceptor Genetic Variant Triggers Vascular Smooth Muscle Cell Hyperproliferation and Agonist Induced Hypertrophy via EGFR Transactivation Pathway.

Authors:  Irina Gradinaru; Ekaterina Babaeva; Debra A Schwinn; Anush Oganesian
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

9.  Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.

Authors:  Saghir Akhtar; Bindu Chandrasekhar; Sreeja Attur; Gursev S Dhaunsi; Mariam H M Yousif; Ibrahim F Benter
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

10.  Knockout of vascular smooth muscle EGF receptor in a mouse model prevents obesity-induced vascular dysfunction and renal damage in vivo.

Authors:  Christian Stern; Barbara Schreier; Alexander Nolze; Sindy Rabe; Sigrid Mildenberger; Michael Gekle
Journal:  Diabetologia       Date:  2020-06-17       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.